News
1d
MyChesCo on MSNWindtree Advances Istaroxime Toward Global Phase 3 Following Positive Interim Study ResultsWARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has reported encouraging interim results from its ongoing ...
Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
Longevity is increasing, and more adults are living to the stage of life when age-related biological factors determine a higher likelihood of cardiovascular disease in a distinctive context of ...
Eight critically ill patients saved through CRRT treatment at Meenakshi Hospital, Thanjavur, showcasing success in advanced therapy for kidney support.
A HF specialty team reviews HF management, assesses suitability for advanced HF therapies and uses palliative care including palliative inotropes where consistent with the patient’s goals of care. 9.
PicEWS outperforms current clinical modelling approaches to predict cardiovascular deterioration. The proposed data processing pipeline and machine learning method offer a clinically applicable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results